Live tape
Top 8, mentions 7d8,941GOOGL1,705 mentions▲ +0.04MRNA1,389 mentions▲ +0.09SNDK1,292 mentions▲ +0.11META1,130 mentions▲ +0.03NVDA1,057 mentions▲ +0.08SPCX903 mentions▲ +0.08NBIS746 mentions▲ +0.09MSFT719 mentions▲ +0.05

Equity · Healthcare

BDX

Becton, Dickinson and Company · NYSE

$187.66 +3.68% 1D Finazon · prior-day close · Aug 19, 2026
Price · Chart
Our own end-of-day closes 61 sessions
$200 $140 22 May 19 Aug

The line runs $147.63 on 22 May through $187.66 on 19 August, on a scale from $140 to $200. Days the market did not trade hold the previous close, flat.

The chart above plots the price of BDX over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 61 sessions over that window: $147.63 on 22 May 2026 through $187.66 on 19 August 2026.

Market cap $51.1B
P/E (TTM) 52.1
52-week range $140.68 – $210.09
Avg volume 340.0K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 20, 2026

BDX insider trades

SEC Form 4 · last 90 days · newest reported trade 13 Aug 2026
Open-market buys 0
Open-market sells 8
Net sold $1.97M
Non-trade filings 7
Date Insider Type Shares Value
13 Aug 2026 Polen Thomas E Jr Chairman, CEO and President Sell 4,152 $768K
11 Aug 2026 Goette Roland EVP and President, EMEA Sell 2,438 $441K
27 Jul 2026 Feld Michael EVP, Chief Revenue Officer Sell 75 $12K
26 Jun 2026 Feld Michael EVP, Chief Revenue Officer Sell 75 $11K
24 Jun 2026 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Sell 1,100 $160K
10 Jun 2026 Garrison Michael David EVP & Pres Med.Essntl&BioPharm Sell 1,100 $167K
01 Jun 2026 Polen Thomas E Jr Chairman, CEO and President Sell 2,764 $405K
26 May 2026 Feld Michael EVP, Chief Revenue Officer Sell 75 $11K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
13 Aug 2026 Polen Thomas E Jr Chairman, CEO and President Option exercise 43,278 $7.24M
13 Aug 2026 Polen Thomas E Jr Chairman, CEO and President Other 39,126 $7.24M
02 Jul 2026 Muhsin Bilal EVP & President Connected Care Tax withheld 1,935
01 Jul 2026 Muhsin Bilal EVP & President Connected Care Award 14,342
01 Jun 2026 Polen Thomas E Jr Chairman, CEO and President Option exercise 20,209 $2.55M
01 Jun 2026 Polen Thomas E Jr Chairman, CEO and President Other 17,445 $2.55M
01 Jun 2026 Menziuso Peter EVP and President, BDI Award 14,258

BDX reported financials

SEC EDGAR XBRL

BDX reported revenue of $21.8B for the fiscal year ended 30 Sep 2025. Net income over the same period was $1.7B.

Figure Reported Period
Revenue $21.8B 30 Sep 2025 fiscal year
Net income $1.7B 30 Sep 2025 fiscal year
Diluted EPS $5.82 30 Sep 2025 fiscal year
Total assets $50.7B 30 Jun 2026 at period end
Total equity $24.4B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

BDX earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q3 2026 $1.37 $4.98B
31 Mar 2026 Q2 2026 $-1.11 $4.71B
31 Dec 2025 Q1 2026 $1.34 $5.25B
30 Sep 2025 FY 2025 $5.82 $21.84B
30 Jun 2025 Q3 2025 $2.00 $4.73B
31 Mar 2025 Q2 2025 $1.07 $4.48B
31 Dec 2024 Q1 2025 $1.04 $5.17B
30 Sep 2024 FY 2024 $5.86 $20.18B

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

BDX institutional holders

SEC Form 13F

9 of the 45 institutional funds we track reported a BDX position for the quarter ended 30 Jun 2026 — a combined $229.2M; the latest of those filings landed 14 Aug 2026.

Fund Action Shares Value
AQR Capital Management Held (±25%) −14.2% shares 650,190 $98.1M
Balyasny Asset Management Added +6,881.7% shares 317,107 $48.0M
Two Sigma Investments Added +703.7% shares 293,839 $44.5M
Citadel Advisors Trimmed −85.7% shares 118,843 $18.0M
Marshall Wace Trimmed −93.8% shares 97,825 $14.8M
Man Group Added +30.9% shares 18,549 $2.8M
GAMCO Investors Held (±25%) −0.5% shares 9,431 $1.4M
Bridgewater Associates Held (±25%) −1.2% shares 9,382 $1.4M
Fisher Asset Management New position 1,429 $216K

Source: SEC EDGAR 13F filings

BDX fails-to-deliver

SEC CNS data

On 31 Jul 2026, 24,362 shares of BDX failed to deliver (about $4.0M) — the latest of 3 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
31 Jul 2026 24,362 $4.0M 0.009%
30 Jul 2026 22 $4K <0.001%
29 Jul 2026 426 $71K <0.001%
27 Jul 2026 19 $3K <0.001%
20 Jul 2026 33,112 $5.2M 0.012%
17 Jul 2026 12 $2K <0.001%
16 Jul 2026 10,733 $1.7M 0.004%
07 Jul 2026 46 $7K <0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in BDX

STOCK Act disclosures

The most recent congressional trade disclosed in BDX is a sale by Thomas H. Kean, Jr. (house, NJ), dated 21 May 2026.

Date Member Type Amount
21 May 2026 filed 18 Jun 2026 Thomas H. Kean, Jr. house · Republican–NJ Sale $1K–$15K
17 Mar 2026 filed 03 Apr 2026 Kevin Hern house · Republican–OK Sale $15K–$50K

Source: U.S. House of Representatives financial disclosures